These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26074050)

  • 1. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
    Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative experiences and donor return: an examination of the role of asking for something different.
    Masser BM; Bove LL; White KM; Bagot KL
    Transfusion; 2016 Mar; 56(3):605-13. PubMed ID: 26472686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the donation experience and reducing venipuncture pain by addressing fears among whole-blood and plasma donors.
    Gilchrist PT; Thijsen A; Masser BM; France CR; Davison TE
    Transfusion; 2021 Jul; 61(7):2107-2115. PubMed ID: 33904178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasovagal reactions in 'at risk' donors: a univariate analysis of effect of age and weight on the grade of donor reactions.
    Tondon R; Pandey P; Chaudhary R
    Transfus Apher Sci; 2008 Oct; 39(2):95-9. PubMed ID: 18753009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood donor haemovigilance in Yaoundé, Cameroon.
    Nchinda EC; Tagny CT; Mbanya D
    Transfus Med; 2012 Aug; 22(4):257-61. PubMed ID: 22630141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse.
    Trouern-Trend JJ; Cable RG; Badon SJ; Newman BH; Popovsky MA
    Transfusion; 1999 Mar; 39(3):316-20. PubMed ID: 10204597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor safety in an individualized plasmapheresis program - Results of an interim analysis.
    Taborski U; Laitinen T
    Transfus Apher Sci; 2022 Oct; 61(5):103446. PubMed ID: 35461780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasovagal reactions in blood donors during or immediately after blood donation.
    Zervou EK; Ziciadis K; Karabini F; Xanthi E; Chrisostomou E; Tzolou A
    Transfus Med; 2005 Oct; 15(5):389-94. PubMed ID: 16202053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic strategies to prevent fainting responses during or after whole blood donation.
    Wieling W; France CR; van Dijk N; Kamel H; Thijs RD; Tomasulo P
    Transfusion; 2011 Dec; 51(12):2727-38. PubMed ID: 21645008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasovagal reaction rates and body weight: findings in high- and low-risk populations.
    Newman BH
    Transfusion; 2003 Aug; 43(8):1084-8. PubMed ID: 12869114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor vigilance: what are we doing about it?
    Wiersum-Osselton JC; Marijt-van der Kreek T; de Kort WL
    Biologicals; 2012 May; 40(3):176-9. PubMed ID: 22230318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fear of blood draws, vasovagal reactions, and retention among high school donors.
    France CR; France JL; Carlson BW; Himawan LK; Stephens KY; Frame-Brown TA; Venable GA; Menitove JE
    Transfusion; 2014 Mar; 54(3 Pt 2):918-24. PubMed ID: 23915025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.